Nisa Investment Advisors LLC decreased its position in shares of MetLife, Inc. (NYSE:MET – Free Report) by 0.4% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 218,285 shares of the financial services provider’s stock after selling 806 shares during the period. Nisa Investment Advisors LLC’s holdings in MetLife were worth $15,321,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Norges Bank purchased a new stake in shares of MetLife in the fourth quarter valued at about $558,460,000. Vanguard Group Inc. increased its position in MetLife by 3.4% in the 1st quarter. Vanguard Group Inc. now owns 59,622,348 shares of the financial services provider’s stock valued at $4,418,612,000 after acquiring an additional 1,974,268 shares during the period. Swedbank AB purchased a new stake in MetLife during the 1st quarter valued at approximately $131,456,000. Dimensional Fund Advisors LP lifted its position in MetLife by 20.9% during the 4th quarter. Dimensional Fund Advisors LP now owns 4,053,851 shares of the financial services provider’s stock worth $268,090,000 after acquiring an additional 700,788 shares during the period. Finally, Bessemer Group Inc. increased its holdings in shares of MetLife by 29.7% in the first quarter. Bessemer Group Inc. now owns 2,120,275 shares of the financial services provider’s stock valued at $157,133,000 after purchasing an additional 485,811 shares during the period. Hedge funds and other institutional investors own 89.81% of the company’s stock.
Analysts Set New Price Targets
Several brokerages recently weighed in on MET. JPMorgan Chase & Co. increased their price target on MetLife from $81.00 to $86.00 and gave the stock an “overweight” rating in a report on Tuesday, July 2nd. Bank of America reduced their target price on shares of MetLife from $99.00 to $96.00 and set a “buy” rating for the company in a research note on Thursday, August 1st. StockNews.com upgraded shares of MetLife from a “hold” rating to a “buy” rating in a research note on Thursday, August 1st. Argus raised their price objective on shares of MetLife from $77.00 to $80.00 and gave the company a “buy” rating in a research report on Wednesday, May 22nd. Finally, Citigroup boosted their target price on MetLife from $83.00 to $89.00 and gave the stock a “buy” rating in a research report on Tuesday, July 23rd. One equities research analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $83.00.
MetLife Stock Up 0.3 %
MET opened at $73.25 on Tuesday. The company has a debt-to-equity ratio of 0.56, a quick ratio of 0.16 and a current ratio of 0.16. The business’s fifty day moving average is $71.83 and its two-hundred day moving average is $71.34. MetLife, Inc. has a one year low of $57.91 and a one year high of $79.34. The company has a market cap of $52.09 billion, a price-to-earnings ratio of 25.17, a PEG ratio of 0.65 and a beta of 1.11.
MetLife (NYSE:MET – Get Free Report) last posted its quarterly earnings data on Wednesday, July 31st. The financial services provider reported $2.28 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.13 by $0.15. The business had revenue of $17.82 billion for the quarter, compared to analysts’ expectations of $18.57 billion. MetLife had a return on equity of 21.41% and a net margin of 4.23%. The business’s revenue was up 7.2% on a year-over-year basis. During the same quarter last year, the firm earned $1.94 earnings per share. Analysts anticipate that MetLife, Inc. will post 8.62 EPS for the current fiscal year.
MetLife Announces Dividend
The business also recently announced a quarterly dividend, which will be paid on Tuesday, September 10th. Investors of record on Tuesday, August 6th will be issued a $0.545 dividend. The ex-dividend date is Tuesday, August 6th. This represents a $2.18 dividend on an annualized basis and a yield of 2.98%. MetLife’s payout ratio is 74.91%.
MetLife declared that its board has authorized a share buyback program on Wednesday, May 1st that authorizes the company to buyback $3.00 billion in outstanding shares. This buyback authorization authorizes the financial services provider to buy up to 6% of its shares through open market purchases. Shares buyback programs are typically an indication that the company’s leadership believes its stock is undervalued.
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Further Reading
- Five stocks we like better than MetLife
- Stock Market Holidays 2022-2025 – Here’s When the NYSE and NASDAQ Will be Closed
- Merck’s Stock Dip Offers a Buying Opportunity: Here’s Why
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 3 Stocks with Surging Call Option Volume in the Recovery Rally
- Roth IRA Calculator: Calculate Your Potential Returns
- 3 High P/E Stocks That Are Still Worth Buying Right Now
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.